Literature DB >> 11782474

FOXC1 transcriptional regulation is mediated by N- and C-terminal activation domains and contains a phosphorylated transcriptional inhibitory domain.

Fred B Berry1, Ramsey A Saleem, Michael A Walter.   

Abstract

Mutations in the FOXC1 gene result in Axenfeld-Rieger malformations of the anterior segment of the eye and lead to an increased susceptibility of glaucoma. To understand how the FOXC1 protein may function in contributing to these malformations, we identified functional regions in FOXC1 required for nuclear localization and transcriptional regulation. Two regions in the FOXC1 forkhead domain, one rich in basic amino acid residues, and a second, highly conserved among all FOX proteins, were necessary for nuclear localization of the FOXC1 protein. However, only the basic region was sufficient for nuclear localization. Two transcriptional activation domains were identified in the extreme N- and C-terminal regions of FOXC1. A transcription inhibitory domain was located at the central region of the protein. This region was able to reduce the trans-activation potential of the C-terminal activation domain, as well as the GAL4 activation domain. Lastly, we demonstrate that FOXC1 is a phosphoprotein, and a number of residues predicted to be phosphorylated were localized to the FOXC1 inhibitory domain. Removal of residues 215-366 resulted in a transcriptionally hyperactive FOXC1 protein, which displayed a reduced level of phosphorylation. These results indicate that FOXC1 is under complex regulatory control with multiple functional domains modulating FOXC1 transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782474     DOI: 10.1074/jbc.M110266200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Essential structural and functional determinants within the forkhead domain of FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; T C Murphy; A Baxevanis; M A Walter
Journal:  Nucleic Acids Res       Date:  2004-08-06       Impact factor: 16.971

2.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 3.  In control of biology: of mice, men and Foxes.

Authors:  Patrick J E C Wijchers; J Peter H Burbach; Marten P Smidt
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

4.  Molecular identification and expression of the Foxl2 gene during gonadal sex differentiation in northern snakehead Channa argus.

Authors:  Dan-Dan Wang; Gui-Rong Zhang; Kai-Jian Wei; Wei Ji; Jonathan P A Gardner; Rui-Bin Yang; Kun-Ci Chen
Journal:  Fish Physiol Biochem       Date:  2015-07-10       Impact factor: 2.794

5.  The transcription factor Foxc1a in zebrafish directly regulates expression of nkx2.5, encoding a transcriptional regulator of cardiac progenitor cells.

Authors:  Yunyun Yue; Mingyang Jiang; Luqingqing He; Zhaojunjie Zhang; Qinxin Zhang; Chun Gu; Meijing Liu; Nan Li; Qingshun Zhao
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

6.  Effects of targeted silencing of FOXC1 gene on proliferation and in vitro migration of human non-small-cell lung carcinoma cells.

Authors:  Sumei Chen; Shunchang Jiao; Youchao Jia; Yang Li
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

7.  FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.

Authors:  Fred B Berry; Megan A O'Neill; Miguel Coca-Prados; Michael A Walter
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 8.  Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.

Authors:  Nadana Sabapathi; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

Review 9.  Epigenetic alterations in a murine model for chronic lymphocytic leukemia.

Authors:  Shih-Shih Chen; Mara H Sherman; Erin Hertlein; Amy J Johnson; Michael A Teitell; John C Byrd; Christoph Plass
Journal:  Cell Cycle       Date:  2009-11-15       Impact factor: 4.534

10.  Novel mutations in the FOXC1 gene in Japanese patients with Axenfeld-Rieger syndrome.

Authors:  Nobuo Fuse; Kana Takahashi; Shunji Yokokura; Kohji Nishida
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.